Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Tuberculosis (Edinburgh, Scotland)|September 21, 2020
Current advances in the clinical development of anti-tubercular agentsSamanvai Reddy Tetali, Eswar Kunapaeddi, Raghu Prasad Mailavaram, et al.
Current Topics in Medicinal Chemistry|December 15, 2020
Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed TherapiesPobitra Borah, Pran K Deb, Katharigatta N Venugopala, et al.
Frontiers in Molecular Biosciences|May 3, 2021
Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19Rajashri Bezbaruah, Pobitra Borah, Bibhuti Bhushan Kakoti, et al.
Acta Pharmaceutica (Zagreb, Croatia)|January 24, 2023
Recent approaches in the drug research and development of novel antimalarial drugs with new targetsNaveen Kumar Reddy Chinnappanna, Gopi Yennam, Chaitanya Budagam Haima Naga Venkata Chaitanya, et al.
Frontiers in Molecular Biosciences|March 8, 2021
Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the UnchartedPobitra Borah, Pran Kishore Deb, Balakumar Chandrasekaran, et al.
Current Drug Metabolism|December 18, 2020
Anticancer Activity and In Silico ADMET Properties of 2,4,5-Trisubstitutedthiazole DerivativesBilal A Al-Jaidi, Soha T Telfah, Sanaa K Bardaweel, et al.
Current Medicinal Chemistry|December 17, 2024
Anticancer and Cyclooxygenase Inhibitory Activity of Benzylidene Derivatives of Fenobam and its Thio AnaloguesWafa Hourani, Pran Kishore Deb, Maysa Alhawamdeh, et al.
Frontiers in Molecular Biosciences|April 19, 2021
Perspectives on RNA Vaccine Candidates for COVID-19Pobitra Borah, Pran Kishore Deb, Nizar A Al-Shar'i, et al.
International Journal of Biological Macromolecules|June 26, 2024
Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studiesKatharigatta N Venugopala, Sandeep Chandrashekharappa, Pran Kishore Deb, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 2, 2021
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzymeKatharigatta N Venugopala, Sandeep Chandrashekharappa, Pran Kishore Deb, et al.
Pageof 3